Celgene quarterly profit rises 17.5 percent

April 27 (Reuters) - U.S. biotechnology company Celgene Corp reported a 17.5 percent jump in quarterly net income on Thursday, helped by demand for its flagship multiple myeloma drug Revlimid.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.